Revenue (Tables)

6 Months Ended

Mar. 31, 2022

Revenue From Contract With Customer [Abstract]

Summary of Revenues Disaggregated by Product Classification and Reportable Segment

The following table presents the Company’s revenues disaggregated by product classification and by reportable segment.

	Three Months Ended March 31,				Six Months Ended March 31,
(In thousands)	2022		2021		2022		2021
Medical Device
Product sales	$	6,441	$	5,410	$	13,229	$	9,971
Royalties		8,358		7,474		15,244		15,383
License fees		1,486		12,578		2,699		14,003
Research, development and other		2,168		2,445		4,189		4,746
Medical Device Revenue		18,453		27,907		35,361		44,103
In Vitro Diagnostics
Product sales		7,523		6,373		13,079		11,914
Research, development and other		130		715		669		1,275
In Vitro Diagnostics Revenue		7,653		7,088		13,748		13,189
Total Revenue	$	26,106	$	34,995	$	49,109	$	57,292